Orphan drug approved to treat rare kidney disorder.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Abstract:
      States that Cystagon (cysteamine bitartrate) was approved by the Food and Drug Administration (FDA) on August 15, 1994 to treat children with nephropathic cystinosis. The Orphan Drug Act.